Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $11.73 billion. The enterprise value is $9.63 billion.
| Market Cap | 11.73B |
| Enterprise Value | 9.63B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025, before market open.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 193.52 million shares outstanding. The number of shares has decreased by -6.82% in one year.
| Current Share Class | 193.52M |
| Shares Outstanding | 193.52M |
| Shares Change (YoY) | -6.82% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 80.06% |
| Float | 161.34M |
Valuation Ratios
The trailing PE ratio is 359.58 and the forward PE ratio is 10.39. Incyte's PEG ratio is 0.09.
| PE Ratio | 359.58 |
| Forward PE | 10.39 |
| PS Ratio | 2.96 |
| Forward PS | 2.47 |
| PB Ratio | 3.40 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | 47.08 |
| P/OCF Ratio | 34.97 |
| PEG Ratio | 0.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 54.22, with an EV/FCF ratio of 38.66.
| EV / Earnings | 295.26 |
| EV / Sales | 2.27 |
| EV / EBITDA | 54.22 |
| EV / EBIT | 114.03 |
| EV / FCF | 38.66 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.97 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.24 |
| Interest Coverage | 37.04 |
Financial Efficiency
Return on equity (ROE) is 0.76% and return on invested capital (ROIC) is 1.21%.
| Return on Equity (ROE) | 0.76% |
| Return on Assets (ROA) | 0.86% |
| Return on Invested Capital (ROIC) | 1.21% |
| Return on Capital Employed (ROCE) | 2.22% |
| Revenue Per Employee | $1.62M |
| Profits Per Employee | $12,463 |
| Employee Count | 2,617 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 45.25 |
Taxes
In the past 12 months, Incyte has paid $284.02 million in taxes.
| Income Tax | 284.02M |
| Effective Tax Rate | 89.70% |
Stock Price Statistics
The stock price has increased by +6.09% in the last 52 weeks. The beta is 0.76, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +6.09% |
| 50-Day Moving Average | 69.58 |
| 200-Day Moving Average | 67.85 |
| Relative Strength Index (RSI) | 30.18 |
| Average Volume (20 Days) | 2,155,469 |
Short Selling Information
The latest short interest is 8.32 million, so 4.30% of the outstanding shares have been sold short.
| Short Interest | 8.32M |
| Short Previous Month | 5.79M |
| Short % of Shares Out | 4.30% |
| Short % of Float | 5.16% |
| Short Ratio (days to cover) | 4.06 |
Income Statement
In the last 12 months, Incyte had revenue of $4.24 billion and earned $32.62 million in profits. Earnings per share was $0.15.
| Revenue | 4.24B |
| Gross Profit | 1.48B |
| Operating Income | 84.45M |
| Pretax Income | 351.14M |
| Net Income | 32.62M |
| EBITDA | 177.60M |
| EBIT | 84.45M |
| Earnings Per Share (EPS) | $0.15 |
Balance Sheet
The company has $2.16 billion in cash and $60.34 million in debt, giving a net cash position of $2.10 billion or $10.84 per share.
| Cash & Cash Equivalents | 2.16B |
| Total Debt | 60.34M |
| Net Cash | 2.10B |
| Net Cash Per Share | $10.84 |
| Equity (Book Value) | 3.45B |
| Book Value Per Share | 17.82 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was $335.34 million and capital expenditures -$86.26 million, giving a free cash flow of $249.07 million.
| Operating Cash Flow | 335.34M |
| Capital Expenditures | -86.26M |
| Free Cash Flow | 249.07M |
| FCF Per Share | $1.29 |
Margins
Gross margin is 35.00%, with operating and profit margins of 1.99% and 0.77%.
| Gross Margin | 35.00% |
| Operating Margin | 1.99% |
| Pretax Margin | 7.47% |
| Profit Margin | 0.77% |
| EBITDA Margin | 4.19% |
| EBIT Margin | 1.99% |
| FCF Margin | 5.87% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.82% |
| Shareholder Yield | 6.82% |
| Earnings Yield | 0.28% |
| FCF Yield | 2.12% |
Analyst Forecast
The average price target for Incyte is $74.00, which is 22.11% higher than the current price. The consensus rating is "Hold".
| Price Target | $74.00 |
| Price Target Difference | 22.11% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 0.94% |
| EPS Growth Forecast (5Y) | 100.46% |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 4.88 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.88 |
| Piotroski F-Score | 5 |